Psl-Dependent Cooperation Contributes to Drug Resistance of Pseudomonas aeruginosa in Dual-Species Biofilms with Acinetobacter baumannii .
Jing WangXi LiuKaiwei YuMoxiao LiuJiuxin QuYingxia LiuZhao CaiKe WangChao ZhuoLiang YangYingdan ZhangPublished in: ACS infectious diseases (2021)
Co-infection of Pseudomonas aeruginosa ( Pa ) and Acinetobacter baumannii ( Ab ) is frequently observed in intensive care unit (ICU) patients but difficult to eliminate. Current clinical practice based on microbial population characterization and single-species-based antibiotic resistance profiling has ignored the potential interspecies interactions, which might lead to novel drug-resistance phenotypes. Here, we investigated the impacts of interspecies interactions on antibiotic therapies by establishing a Pa and Ab dual-species biofilm model. Our data showed that antibiotic exposure would reshape the community compositions of dual-species biofilms, and those of the extracellular polymeric substance (EPS) matrix of Pa , Psl exopolysaccharide in particular, promoted its interactions with Ab against imipenem stress. We further found other EPS structural fiber-eDNA contributed to the Psl-dependent dual-species biofilm stability under antibiotic treatment. Thus, targeting the EPS structural fibers such as Psl and extracellular DNA (eDNA) is a potent strategy for controlling polymicrobial biofilm related infections.
Keyphrases
- pseudomonas aeruginosa
- acinetobacter baumannii
- cystic fibrosis
- intensive care unit
- biofilm formation
- drug resistant
- multidrug resistant
- candida albicans
- staphylococcus aureus
- clinical practice
- end stage renal disease
- chronic kidney disease
- healthcare
- genetic diversity
- ejection fraction
- cancer therapy
- mental health
- newly diagnosed
- risk assessment
- single molecule
- prognostic factors
- single cell
- cell free
- electronic health record
- peritoneal dialysis
- high speed
- drug induced